Using ICDs in patients with LVADs may lower mortality rates in advanced heart failure patients |
Twitter alerts cardiologist on public heart health data |
4 policies to improve the identification of patients with diabetes and cardiovascular disease |
ACC expands cardiovascular disease prevention program to 9 countries |
More issues arise with the HeartWare HVAD system |
Shockwave Medical’s lithoplasty system achieves primary endpoint in single-arm study |
University fellowship program addresses shortage of minority cardiologists |
Abiomed Impella 2.5™and Impella 5.0™ Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare |
NHLBI names David Goff director of cardiovascular sciences division |
Amgen expands CV portfolio with 2 agreements with Arrowhead Pharmaceuticals |
Disappearing act: Nevada Heart and Vascular implants dissolving heart stent |
Despite reimbursement changes, cardiologists’ compensation continues to increase |
Higher resting heart rates in African Americans are associated with increased mortality, hospitalizations |
Data-based Evidence Drives Efficient Cath Lab Inventory Management |
Queen Latifah to receive award from the Association of Black Cardiologists |
9 benefits to having an AED in the workplace |
Bystander CPR program improves neurologic outcomes after out-of-hospital cardiac arrest |
FDA clears Medtronic’s catheter for use in the peripheral vascular system |
CardioFocus Begins U.S. Commercialization of HeartLight® System for Paroxysmal Atrial Fibrillation with First Procedure at Mount Sinai |
Dialysis organizations team up with CDC to protect patients |
NIH awards $37 million for chelation therapy trial in patients with a prior MI, diabetes |
Artificial blood vessels may reduce need for multiple surgeries in young heart patients |
HCI3 not pleased with CMS’s new bundled payment plan for cardiology treatments |
Chronic stroke survivors may benefit from electrical stimulation |
Early detection, surgery shorten recovery time for stroke victims |
Statin, nonstatin therapies may have similar relative risks of major vascular events |
Ambulances better equipped to help people suffering from cardiac arrest |
Abiomed Impella 2.5(TM)and Impella 5.0(TM) Heart Pumps Receive Regulatory Approval From Japan Ministry of Health, Labor & Welfare |
National Lipid Association asks members to complete survey on PCSK9 inhibitors |
Chagas parasitic heart disease threat creeps into U.S. |
Increased abdominal fat may boost cardiovascular disease risk factors |
Automated dispenser simplifies managing multiple medications |
Cardiologist hopes combination medication can prevent MIs, save lives |
Drinking tea may improve cardiovascular health |
Cardiologists, primary care physicians share in bridging anticoagulation management |
AHA creates tech center, encourages engagement from industry players |
Women on the heart transplant list face a greater risk of death |
Obesity epidemic threatens to end trend of longer lifespans |
Treatment with colchicine is not linked to reducing cardiovascular mortality |
Heart failure medication may lower risk of cardiovascular death, hospitalizations |
Retired surgeon admits he lied to protect partner in malpractice lawsuit |
Developing infective endocarditis following TAVR is associated with high mortality rates |
Texas hospital first to use new heart catheter device |
Intravascular study of PCSK9 inhibitor meets primary and secondary endpoints |
New iPhone 7 app helps save lives |
Heart Institute of the Caribbean founder receives award from UPenn |
Open and endovascular AAA repair have similar cost-effectiveness and survival rates |
SpringBoard Healthcare Launches Cath Lab, EP and IR Wage Survey |
NHLBI awards $8 million grant for study to create a bioengineered, human heart tissue patch |
UCLA researchers find molecule that could delay, prevent heart failure |
Coronary angiography, PCI use following out-of-hospital cardiac arrest increases from 2000 to 2012 |
Smoking has a lasting effect on the human genome |
New 'super' type 2 diabetes medication gets FDA approval |
Quality improvement program improves recognition, treatment of STEMI |
Medtronic Valiant Captivia Demonstrates Safety and Efficacy at Three Years |
CMS certifies Mississippi hospital for ventricular assist device therapy |
MyoKardia Outlines Path to Registration for MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients and Provides Pipeline and Research Updates at Inaugural R&D Day |
Loma Linda University receives patent for the use of nitrite to treat specific cardiovascular conditions |
Investigational medication lowers cardiovascular risk in type 2 diabetic patients |
Medtronic hires Mark Ploof as senior vice president |
Wearable technology may not help people lose weight |
New wearable heart monitoring device connects with users' phones |
Alternative to high risk surgery? New TAVI device approved in Europe |
Thyroid hormone levels may help predict risk of sudden cardiac death |
AHA releases statement on the link between sleep disorders, cardiovascular health |
Earlier menopause could increase risk for poor cardiovascular outcomes |
EBR Systems receives FDA approval to start clinical trial of its wireless cardiac pacing system |
Depression during pregnancy linked to gestational diabetes |
3 reasons patients should call 9-1-1 when having a heart attack |
6 tips for adopting a whole food, plant-based diet from NY cardiologist |
New sound therapy can reduce blood pressure in hypertensive patients |
AHA seeks public comment for recommendations on use of telephone CPR |
Mayors in five cities participate in weekly walks to raise heart disease awareness |
Chronic kidney disease, hypertension are common after children undergo cardiac surgery |
Probiotics do the heart good |
FDA clears Shockwave Medical’s lithoplasty system for patients with peripheral artery disease |
Shockwave Medical Announces FDA Clearance of the Company’s Lithoplasty® System, the First and Only Technology to Use Sound Waves to Treat Calcified Peripheral Artery Disease |
Donald Trump releases cardiovascular test data and other medical information |
Novo Nordisk recalls six batches of the GlucaGen HypoKit |
Researchers develop ointment to reverse neuropathy in diabetic patients |
Easier to stomach? New aspirin drug promises fewer gastric ulcers |
Hillary Clinton releases updated medical information after pneumonia diagnosis |
Considerable variability exists among cardiovascular guidelines |
The Journal of the American Medical Association Publishes Medtronic's Hybrid Closed Loop System Pivotal Trial Results |
Drinking one alcoholic drink a day may increase risk of atrial fibrillation |
Intensive blood pressure management may be cost-effective |
FDA approves the IN.PACT balloon to treat in-stent restenosis |
Endovascular therapy trumps tPA for distal stroke clot treatment |
AHA calls for elimination of childhood exposure to secondhand smoke |
Claret Medical Announces Sentinel Pivotal IDE Trial to be Featured in Late-breaking Trial Session at Transcatheter Cardiovascular Therapeutics (TCT) Conference |
More than 25% of Medicare beneficiaries are nonadherent to antihypertensives |
Cardiovascular Research Foundation announces late-breaking trials for TCT conference |
Long-term effectiveness of mobile, internet health interventions remain uncertain |
Light therapy could offer same benefits as electric shock defibrillation after MI |
Electrical stimulation therapy improves manual dexterity among stroke patients |
Cardiologist says Hillary Clinton likely had an episode of syncope |
Nearly 75% of cardiothoracic surgeons are satisfied with careers |
WellDoc® Announces Agreement with LifeScan Inc., a Johnson & Johnson Diabetes Care Company, to Finalize Commercial Partnership to Deliver Combined, Best-in-Class Digital Therapeutic Solution for Patients with Type 2 Diabetes |
Colibri Heart Valve Enters Agreement with Venus Medtech to Form Joint Venture to Develop Next-Generation Transcatheter Heart Valve Technologies |
FDA approves disposable glucose sensor for patients with type 2 diabetes |